EWM
AMRI

Evercore Wealth Management’s Albany Molecular Research Inc AMRI Stock Holding History

Evercore Wealth Management’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-886,031
Closed -$19.2M – 983
2017
Q2 		$19.2M Sell
886,031
-154,180
-15% -$2.8M 0.74% 41
2017
Q1 		$14.6M Sell
1,040,211
-12,230
-1% -$200K 0.57% 46
2016
Q4 		$19.7M Sell
1,052,441
-107,787
-9% -$1.83M 0.82% 42
2016
Q3 		$19.2M Hold
1,160,228
– – 0.79% 45
2016
Q2 		$15.6M Buy
1,160,228
+87,787
+8% +$1.28M 0.69% 45
2016
Q1 		$16.4M Hold
1,072,441
– – 0.72% 45
2015
Q4 		$21.3M Sell
1,072,441
-161,439
-13% -$3.07M 0.99% 36
2015
Q3 		$21.5M Hold
1,233,880
– – 1.03% 37
2015
Q2 		$24.9M Sell
1,233,880
-68,400
-5% -$1.32M 1.13% 34
2015
Q1 		$22.9M Hold
1,302,280
– – 1.05% 32
2014
Q4 		$21.2M Sell
1,302,280
-5,000
-0.4% -$91.8K 1.06% 36
2014
Q3 		$28.9M Sell
1,307,280
-24,200
-2% -$496K 1.45% 19
2014
Q2 		$26.8M Hold
1,331,480
– – 1.38% 20
2014
Q1 		$24.8M Sell
1,331,480
-31,000
-2% -$427K 1.39% 18
2013
Q4 		$13.7M Sell
1,362,480
-13,500
-1% -$163K 0.75% 49
2013
Q3 		$17.7M Sell
1,375,980
-19,000
-1% -$234K 1.02% 27
2013
Q2 		$16.6M Buy
+1,394,980
New +$15.1M 0.94% 30

Other funds holding AMRI

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Evercore Wealth Management's AMRI Position: Q3 2017 in Review

Evercore Wealth Management sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 886,031 shares — an estimated $19.2M sold.

Evercore Wealth Management first reported a position in AMRI in Q2 2013 and held it in 17 quarters. The position peaked at $28.9M in Q3 2014. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

  • Evercore Wealth Management reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
  • Evercore Wealth Management sold 886,031 Albany Molecular Research Inc shares in Q3 2017, an estimated $19.2M.
  • Evercore Wealth Management first reported a position in Albany Molecular Research Inc in Q2 2013 and held it in 17 quarters.
  • Evercore Wealth Management's Albany Molecular Research Inc position peaked at $28.9M in Q3 2014.
  • 2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on Evercore Wealth Management's 13F filing for Q3 2017, filed 13 Nov 2017.